Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns Meeting Abstract


Authors: Sahai, V.; Tabernero, J.; Van Cutsem, E.; Reni, M.; Tempero, M. A.; O'Reilly, E. M.; Berlin, J.; Riess, H.; Goldstein, D.; Li, M.; Lu, B.; Ferrara, S.; Philip, P. A.
Abstract Title: Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns
Meeting Title: 2020 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 4 Suppl.
Meeting Dates: 2020 Jan 23-25
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-02-01
Language: English
ACCESSION: WOS:000530922700678
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.4_suppl.704
Notes: Meeting Abstract: 704 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eileen O'Reilly
    780 O'Reilly